Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Psychological Resilience
NCT00331799Phase 2Completed
- Sponsor
- Duke University
- Start
- Apr 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of duloxetine in major depressive disorder (MDD), sponsored by Duke University. Started Apr 2007; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00331799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00331799.